Ray Amrit 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Apr 22, 2022
Insider Transaction Report
Form 4
Ray Amrit
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-19+9,525→ 9,525 totalExercise: $78.10Exp: 2032-04-19→ Common Stock (9,525 underlying) - Award
Common Stock
2022-04-19+5,120→ 5,120 total
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]The option shall vest with respect to 1/36th of the shares monthly such that the option shall be fully vested on the third anniversary of the grant date.